Literature DB >> 26875099

Relative sensitivity of immunohistochemistry, multiple reaction monitoring mass spectrometry, in situ hybridization and PCR to detect Coxsackievirus B1 in A549 cells.

Jutta E Laiho1, Maarit Oikarinen2, Sarah J Richardson3, Gun Frisk4, Julius Nyalwidhe5, Tanya C Burch6, Margaret A Morris7, Sami Oikarinen8, Alberto Pugliese9, Francesco Dotta10, Martha Campbell-Thompson11, Jerry Nadler12, Noel G Morgan13, Heikki Hyöty14.   

Abstract

BACKGROUND: Enteroviruses (EVs) have been linked to the pathogenesis of several diseases and there is a collective need to develop improved methods for the detection of these viruses in tissue samples.
OBJECTIVES: This study evaluates the relative sensitivity of immunohistochemistry (IHC), proteomics, in situ hybridization (ISH) and RT-PCR to detect one common EV, Coxsackievirus B1 (CVB1), in acutely infected human A549 cells in vitro. STUDY
DESIGN: A549 cells were infected with CVB1 and diluted with uninfected A549 cells to produce a limited dilution series in which the proportion of infected cells ranged from 10(-1) to 10(-8). Analyses were carried out by several laboratories using IHC with different anti-EV antibodies, ISH with both ViewRNA and RNAScope systems, liquid chromatography multiple reaction monitoring mass spectrometry (LC/MRM/MS/MS), and two modifications of RT-PCR.
RESULTS: RT-PCR was the most sensitive method for EV detection yielding positive signals in the most diluted sample (10(-8)). LC/MRM/MS/MS detected viral peptides at dilutions as high as 10(-7). The sensitivity of IHC depended on the antibody used, and the most sensitive antibody (Dako clone 5D8/1) detected virus proteins at a dilution of 10(-6), while ISH detected the virus at dilutions of 10(-4).
CONCLUSIONS: All methods were able to detect CVB1 in infected A549 cells. RT-PCR was most sensitive followed by LC/MRM/MS/MS and then IHC. The results from this in vitro survey suggest that all methods are suitable tools for EV detection but that their differential sensitivities need to be considered when interpreting the results from such studies.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Immunohistochemisrty; In situ hybridization; Proteomics; RT-PCR; Sensitivity

Mesh:

Year:  2016        PMID: 26875099      PMCID: PMC5364806          DOI: 10.1016/j.jcv.2016.01.015

Source DB:  PubMed          Journal:  J Clin Virol        ISSN: 1386-6532            Impact factor:   3.168


  16 in total

Review 1.  The role of enterovirus in chronic fatigue syndrome.

Authors:  J K S Chia
Journal:  J Clin Pathol       Date:  2005-11       Impact factor: 3.411

Review 2.  Coxsackievirus myocarditis: interplay between virus and host in the pathogenesis of heart disease.

Authors:  Patricia E Tam
Journal:  Viral Immunol       Date:  2006       Impact factor: 2.257

3.  Skyline: an open source document editor for creating and analyzing targeted proteomics experiments.

Authors:  Brendan MacLean; Daniela M Tomazela; Nicholas Shulman; Matthew Chambers; Gregory L Finney; Barbara Frewen; Randall Kern; David L Tabb; Daniel C Liebler; Michael J MacCoss
Journal:  Bioinformatics       Date:  2010-02-09       Impact factor: 6.937

Review 4.  Enteroviruses and type 1 diabetes: towards a better understanding of the relationship.

Authors:  Hela Jaïdane; Pierre Sauter; Famara Sane; Anne Goffard; Jawhar Gharbi; Didier Hober
Journal:  Rev Med Virol       Date:  2010-09       Impact factor: 6.989

5.  Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry? Reply to Hansson SF, Korsgren S, Pontén F et al [letter].

Authors:  Sarah J Richardson; Pia Leete; Shalinee Dhayal; Mark A Russell; Maarit Oikarinen; Jutta E Laiho; Emma Svedin; Katharina Lind; Therese Rosenling; Nora Chapman; Adrian J Bone; Alan K Foulis; Gun Frisk; Malin Flodström-Tullberg; Didier Hober; Heikki Hyoty; Alberto Pugliese; Noel G Morgan
Journal:  Diabetologia       Date:  2014-01-16       Impact factor: 10.122

6.  Development and evaluation of a micro- and nanoscale proteomic sample preparation method.

Authors:  Haixing Wang; Wei-Jun Qian; Heather M Mottaz; Therese R W Clauss; David J Anderson; Ronald J Moore; David G Camp; Arshad H Khan; Daniel M Sforza; Maria Pallavicini; Desmond J Smith; Richard D Smith
Journal:  J Proteome Res       Date:  2005 Nov-Dec       Impact factor: 4.466

7.  Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technology.

Authors:  Jutta E Laiho; Sami Oikarinen; Maarit Oikarinen; Pär G Larsson; Virginia M Stone; Didier Hober; Steven Oberste; Malin Flodström-Tullberg; Jorma Isola; Heikki Hyöty
Journal:  J Clin Virol       Date:  2015-06-23       Impact factor: 3.168

8.  Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas.

Authors:  Sarah J Richardson; Pia Leete; Shalinee Dhayal; Mark A Russell; Maarit Oikarinen; Jutta E Laiho; Emma Svedin; Katharina Lind; Therese Rosenling; Nora Chapman; Adrian J Bone; Alan K Foulis; Gun Frisk; Malin Flodstrom-Tullberg; Didier Hober; Heikki Hyoty; Noel G Morgan
Journal:  Diabetologia       Date:  2013-11-05       Impact factor: 10.122

9.  Human enterovirus 71 strains in the background population and in hospital patients in Finland.

Authors:  Hanna Honkanen; Sami Oikarinen; Outi Pakkanen; Tanja Ruokoranta; Minna M Pulkki; Olli H Laitinen; Sisko Tauriainen; Sanna Korpela; Maija Lappalainen; Tytti Vuorinen; Anna-Maija Haapala; Riitta Veijola; Olli Simell; Jorma Ilonen; Mikael Knip; Heikki Hyöty
Journal:  J Clin Virol       Date:  2012-12-21       Impact factor: 3.168

10.  Type 1 diabetes is associated with enterovirus infection in gut mucosa.

Authors:  Maarit Oikarinen; Sisko Tauriainen; Sami Oikarinen; Teemu Honkanen; Pekka Collin; Immo Rantala; Markku Mäki; Katri Kaukinen; Heikki Hyöty
Journal:  Diabetes       Date:  2012-02-07       Impact factor: 9.461

View more
  13 in total

1.  Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter].

Authors:  Jessica L Dunne; Sarah J Richardson; Mark A Atkinson; Maria E Craig; Knut Dahl-Jørgensen; Malin Flodström-Tullberg; Heikki Hyöty; Richard E Lloyd; Noel G Morgan; Alberto Pugliese
Journal:  Diabetologia       Date:  2019-04-23       Impact factor: 10.122

Review 2.  Enteroviral Infections as a Trigger for Type 1 Diabetes.

Authors:  Teresa Rodriguez-Calvo
Journal:  Curr Diab Rep       Date:  2018-09-19       Impact factor: 4.810

3.  In situ hybridization of feline leukemia virus in a primary neural B-cell lymphoma.

Authors:  Anna Szilasi; Lilla Dénes; Csaba Jakab; Ildikó Erdélyi; Talita Resende; Fabio Vannucci; Judit Csomor; Míra Mándoki; Gyula Balka
Journal:  J Vet Diagn Invest       Date:  2020-04-10       Impact factor: 1.279

4.  Choice for Drug or Natural Reward Engages Largely Overlapping Neuronal Ensembles in the Infralimbic Prefrontal Cortex.

Authors:  Simone Pfarr; Laura Schaaf; Janine K Reinert; Elisabeth Paul; Frank Herrmannsdörfer; Martin Roßmanith; Thomas Kuner; Anita C Hansson; Rainer Spanagel; Christoph Körber; Wolfgang H Sommer
Journal:  J Neurosci       Date:  2018-02-26       Impact factor: 6.167

Review 5.  Genomic tools for behavioural ecologists to understand repeatable individual differences in behaviour.

Authors:  Sarah E Bengston; Romain A Dahan; Zoe Donaldson; Steven M Phelps; Kees van Oers; Andrew Sih; Alison M Bell
Journal:  Nat Ecol Evol       Date:  2018-02-12       Impact factor: 19.100

6.  A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses.

Authors:  Niila V V Saarinen; Jutta E Laiho; Sarah J Richardson; Marie Zeissler; Virginia M Stone; Varpu Marjomäki; Tino Kantoluoto; Marc S Horwitz; Amirbabak Sioofy-Khojine; Anni Honkimaa; Minna M Hankaniemi; Malin Flodström-Tullberg; Heikki Hyöty; Vesa P Hytönen; Olli H Laitinen
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

7.  Detection and localization of viral infection in the pancreas of patients with type 1 diabetes using short fluorescently-labelled oligonucleotide probes.

Authors:  Niels Busse; Federico Paroni; Sarah J Richardson; Jutta E Laiho; Maarit Oikarinen; Gun Frisk; Heikki Hyöty; Eelco de Koning; Noel G Morgan; Kathrin Maedler
Journal:  Oncotarget       Date:  2017-02-21

Review 8.  Enteroviral infections in the pathogenesis of type 1 diabetes: new insights for therapeutic intervention.

Authors:  Sarah J Richardson; Noel G Morgan
Journal:  Curr Opin Pharmacol       Date:  2018-07-29       Impact factor: 5.547

9.  Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III.

Authors:  Joshua E Messinger; Joanne Dai; Lyla J Stanland; Alexander M Price; Micah A Luftig
Journal:  mBio       Date:  2019-07-02       Impact factor: 7.867

10.  The Four-Way Stop Sign: Viruses, 12-Lipoxygenase, Islets, and Natural Killer Cells in Type 1 Diabetes Progression.

Authors:  Michele L Semeraro; Lindsey M Glenn; Margaret A Morris
Journal:  Front Endocrinol (Lausanne)       Date:  2017-09-25       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.